LL-37

01 · What is it?

The identity comes first.

LL-37 is a peptide produced from a larger precursor in the body’s innate defense system. It can interact with microbes and human cells. A natural defense role does not make additional LL-37 uniformly beneficial.

Scientific classification: Endogenous human cathelicidin antimicrobial peptide

For example. A security signal can help in one setting and amplify an unwanted alarm in another.

02 · How does it work?

The signal, explained.

It can interact directly with microbial membranes and can also send signals to human cells. Those different actions can change immune activity in different directions.

The key research focus is Microbial membranes; context-dependent host targets including FPR2. A target describes where an interaction may occur; it does not by itself establish a benefit.

03 · What happens after the signal?

Follow the downstream effects.

Membrane effects can impair microbes in vitro; host signaling can influence chemotaxis, cytokines and wound responses. Some contexts involve pro-inflammatory or disease-promoting effects.

To connect this mechanism to a real-world outcome, researchers need to establish exposure at the target, measure the response and test whether the change matters in a controlled human study.

04 · What is it commonly researched for?

The questions researchers are asking.

Researchers have investigated antimicrobial activity, skin wounds and immune signaling.

These are areas of investigation, not promises about a Maison product.

05 · Body systems involved

Where the biology connects.

Skin

Includes barrier tissue, fibroblasts and hair follicles where applicable; cell findings are not automatically clinical outcomes.

Immune system

Immune-cell signaling and cytokine responses are context-dependent.

Digestive tract

Relevant to secretion, motility, epithelial transport or gut–brain signaling.

06 · Receptor / target profile

The molecular reference card.

Primary receptor or target

Microbial membranes; context-dependent host targets including FPR2

Secondary interactions

Multiple host interactions; do not describe FPR2 as its only target.

Where it is found

Skin; Immune system; Digestive tract

Activation, inhibition or interaction

Its amphipathic structure supports membrane interactions. Host-cell signaling involves multiple reported targets, including formyl peptide receptor 2, depending on experimental context.

Important downstream pathways

Membrane effects can impair microbes in vitro; host signaling can influence chemotaxis, cytokines and wound responses. Some contexts involve pro-inflammatory or disease-promoting effects.

07 · Evidence quality

What carries weight—and what does not.

A familiar mechanism, a patent, a testimonial or a trial registration alone cannot establish human efficacy or product quality.

08 · Who is studying it?

Follow the original research.

No current sponsor-led clinical development program was verified for this exact research identity. This does not prove that no study exists; consult current records and distinguish related molecules.

Regulatory context: No approved medical use for this research identity was established in the sources reviewed. This is not a determination of authorization in every country. The research material discussed here must not be assumed equivalent to a licensed medicine.

Registry links may include related compounds or historical studies. Read the exact intervention, sponsor, phase and latest update date. Recruitment status is specific to each trial.

09 · Research terminology

A small glossary for this page.

Explore the complete foundations glossary

10 · Research status & limitations

Keep the boundaries visible.

No approved medical use for this research identity was established in the sources reviewed. This is not a determination of authorization in every country. The research material discussed here must not be assumed equivalent to a licensed medicine.

Long-term outcomes, comparative benefit, clinically meaningful effects and safety for broad wellness use are not well established.

The main evidence category here is preclinical or animal research. The exact molecule, formulation, study population and endpoint matter. Scientific evidence changes; this page is a dated educational summary, not continuous trial monitoring.